Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo

导出原文传递

翻译打印收藏纠错

作者： Palma, M. L. ^[1] ; Duangkhae, P. ^[2] ; Douradinha, B. ^[3] ; Viana, I. F. T. ^[4] ; Rigato, P. O. ; Dhalia, R. ; Mailliard, R. B. ; Barratt-Boyes, S. M. ; Nascimento, E. J. M. ; Oshiro, T. M. ; da Silva Duarte, A. J. ; Marques, E. T. A.

作者单位： Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil ^[1] Univ Pittsburgh, Ctr Vaccine Res, 3501 Fifth Ave,9th Floor, Pittsburgh, PA USA ^[2] Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Virol Dept, Recife, PE, Brazil ^[3] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA ^[4]

发布时间 2018-01-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Gene therapy

2017年24卷6期

342-352页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo

Gene therapy

相似文献

Gene therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo

Gene therapy

相似文献

Gene therapy

相关期刊

检索历史清除